Furthermore, we confirmed that high TNFRSF1B expression in primary CD8+T cells resulted in reduced IFN‐γ production, which is necessary for tumour‐killing activity in T cells, determine the mechanistic factors leading to the pro‐tumorigenic effects of TNFRSF1B. The gene discussed is CD8A; the disease is neoplasm.